| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| 4D Molecular Therapeutics Inc. | Chief Business Officer | Stock Option (Right to Buy) | 35,000 | 01 Feb 2022 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| FDMT | 4D Molecular Therapeutics Inc. | 01 Feb 2022 | 1 | $0 | 4 | Chief Business Officer | 03 Feb 2022, 16:42 |
| FDMT | 4D Molecular Therapeutics Inc. | 07 Jun 2021 | 1 | $0 | 4 | Chief Business Officer | 09 Jun 2021, 20:28 |
| FDMT | 4D Molecular Therapeutics Inc. | 07 Jun 2021 | 0 | $0 | 3 | Chief Business Officer | 09 Jun 2021, 20:21 |